The transaction if completed would have positioned the Hyderabad-based firm as the second largest dermatology player and the second largest generics company in the US by prescriptions.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/349UyRR
via IFTTT
0 comments:
Post a Comment